MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1177/12034754251408391

Медицинская библиотека · Journal of cutaneous medicine and surgery · 2025

Intramuscular Triamcinolone Acetonide Versus Oral Minipulse Dexamethasone in Active Vitiligo: An Observational Study.

Chaiyabutr Chayada, Kunavisarut Tada, Wannawittayapa Teerapat, Pruksaeakanan Chutipon, Wongpraparut Chanisada, Silpa-Archa Narumol

СтатьяНаблюдательное исследованиеСравнительное исследованиеПеревод в очереди

Аннотация

BACKGROUND

Systemic corticosteroids, particularly oral minipulse dexamethasone (OMP-D), are commonly used to stabilize active vitiligo. Intramuscular triamcinolone acetonide (IMTA), though effective in other dermatoses, has limited studies for vitiligo.

OBJECTIVES

To compare the efficacy and safety of IMTA versus OMP-D in adults with active vitiligo.

METHODS

This observational study included patients aged 18 to 60 years with clinically active vitiligo. Patients received either IMTA 40 mg monthly or OMP-D 2.5 mg twice weekly for 3 months. Vitiligo extent score (VES) and adverse events were assessed at baseline, months 1, 2, 3, and 6. Biochemical parameters were evaluated at baseline and month 3.

RESULTS

Nineteen patients (9 in the IMTA group and 10 in the OMP-D group) were included. All patients achieved disease stabilization within the first month. The IMTA group showed an earlier onset of repigmentation, evidenced by a significant reduction in VES at month 1. By months 2, 3, and 6, both groups demonstrated significant reductions in VES compared to baseline. Notably, at months 2 and 3, the OMP-D group exhibited a more pronounced decrease in VES (P ≤ .01) than the IMTA group (P ≤ .05). One patient in the IMTA group began to experience vitiligo relapse at month 6. Both treatments were well-tolerated. Cortisol suppression was observed in 1 patient from each group.

CONCLUSIONS

IMTA shows promising results, comparable in efficacy and safety to OMP-D for active vitiligo, achieving early disease stabilization and repigmentation. IMTA represents a practical first-line alternative for active vitiligo management.

Для цитирования: Chaiyabutr Chayada, Kunavisarut Tada, Wannawittayapa Teerapat, Pruksaeakanan Chutipon, Wongpraparut Chanisada, Silpa-Archa Narumol. Intramuscular Triamcinolone Acetonide Versus Oral Minipulse Dexamethasone in Active Vitiligo: An Observational Study.. Journal of cutaneous medicine and surgery. 2025. DOI: 10.1177/12034754251408391.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.